Zobrazeno 1 - 10
of 656
pro vyhledávání: '"Christova R"'
Autor:
Shenoy, T.R., Boysen, G., Wang, M.Y., Xu, Q.Z., Guo, W., Koh, F.M., Wang, C., Zhang, L.Z., Wang, Y., Gil, V., Aziz, S., Christova, R., Rodrigues, D.N., Crespo, M., Rescigno, P., Tunariu, N., Riisnaes, R., Zafeiriou, Z., Flohr, P., Yuan, W., Knight, E., Swain, A., Ramalho-Santos, M., Xu, D.Y., de Bono, J. *, Wu, H. *
Publikováno v:
In Annals of Oncology July 2017 28(7):1495-1507
Autor:
Seed, G., Greening, S., Goodall, J., Rekowski, J., Christova, R., Mehra, N., Eisenberger, M., Fizazi, K., Tombal, B., Wülfing, C., Sternberg, C.N., Castellano Gauna, D.E., Oudard, S., Sartor, O., Geffriaud-Ricouard, C., Chadjaa, M., Mace, S., Carreira, S., Yuan, W., de Bono, J.S.
Publikováno v:
In Annals of Oncology October 2023 34 Supplement 2:S996-S997
Autor:
de Bono JS; The Institute of Cancer Research, Royal Cancer Hospital, London, UK., Harris JR; Genmab, Plainsboro, New Jersey, USA., Burm SM; Genmab, Utrecht, The Netherlands., Vanderstichele A; Department of Gynaecology and Obstetrics, Division of Gynaecologic Oncology, University Hospitals Leuven, Leuven Cancer Institute, Leuven, Belgium., Houtkamp MA; Genmab, Utrecht, The Netherlands., Aarass S; Genmab, Plainsboro, New Jersey, USA.; Genmab, Utrecht, The Netherlands., Riisnaes R; The Institute of Cancer Research, Royal Cancer Hospital, London, UK., Figueiredo I; The Institute of Cancer Research, Royal Cancer Hospital, London, UK., Nava Rodrigues D; The Institute of Cancer Research, Royal Cancer Hospital, London, UK., Christova R; The Institute of Cancer Research, Royal Cancer Hospital, London, UK., Olbrecht S; Department of Gynaecology and Obstetrics, Division of Gynaecologic Oncology, University Hospitals Leuven, Leuven Cancer Institute, Leuven, Belgium., Niessen HWM; Department of Pathology, VU Medical Center, Amsterdam, The Netherlands., Ruuls SR; Lava Therapeutics, Utrecht, The Netherlands., Schuurhuis DH; Genmab, Utrecht, The Netherlands., Lammerts van Bueren JJ; Merus, Utrecht, The Netherlands., Breij ECW; Genmab, Utrecht, The Netherlands., Vergote I; Department of Gynaecology and Obstetrics, Division of Gynaecologic Oncology, University Hospitals Leuven, Leuven Cancer Institute, Leuven, Belgium.
Publikováno v:
Cancer reports (Hoboken, N.J.) [Cancer Rep (Hoboken)] 2023 Feb; Vol. 6 (2), pp. e1699. Date of Electronic Publication: 2022 Aug 13.
Autor:
Mehra, N., Dolling, D., Sumanasuriya, S., Christova, R., Pope, L., Carreira, S., Seed, G., Yuan, W., Goodall, J., Hall, E., Flohr, P., Boysen, G., Bianchini, D., Sartor, O., Eisenberger, M.A., Fizazi, K., Oudard, S., Chadjaa, M., Mace, S., Bono, J.S. de
Publikováno v:
European Urology, 74, 3, pp. 283-291
European Urology
European Urology, 74, 283-291
European Urology
European Urology, 74, 283-291
Background Noninvasive biomarkers are needed to guide metastatic castration-resistant prostate cancer (mCRPC) treatment. Objective To clinically qualify baseline and on-treatment cell-free DNA (cfDNA) concentrations as biomarkers of patient outcome f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::b8beada809cd296df08023026dd2629e
https://hdl.handle.net/2066/196653
https://hdl.handle.net/2066/196653
Autor:
Gil V; The Institute of Cancer Research, London, United Kingdom., Miranda S; The Institute of Cancer Research, London, United Kingdom., Riisnaes R; The Institute of Cancer Research, London, United Kingdom.; The Royal Marsden Hospital, London, United Kingdom., Gurel B; The Institute of Cancer Research, London, United Kingdom., D'Ambrosio M; Institute of Oncology Research, Università della Svizzera Italiana, Bellinzona, Switzerland., Vasciaveo A; Columbia University College of Physicians and Surgeons, New York, New York., Crespo M; The Institute of Cancer Research, London, United Kingdom.; The Royal Marsden Hospital, London, United Kingdom., Ferreira A; The Institute of Cancer Research, London, United Kingdom., Brina D; Institute of Oncology Research, Università della Svizzera Italiana, Bellinzona, Switzerland., Troiani M; Institute of Oncology Research, Università della Svizzera Italiana, Bellinzona, Switzerland., Sharp A; The Institute of Cancer Research, London, United Kingdom.; The Royal Marsden Hospital, London, United Kingdom., Sheehan B; The Institute of Cancer Research, London, United Kingdom., Christova R; The Institute of Cancer Research, London, United Kingdom., Seed G; The Institute of Cancer Research, London, United Kingdom., Figueiredo I; The Institute of Cancer Research, London, United Kingdom., Lambros M; The Institute of Cancer Research, London, United Kingdom., Dolling D; The Institute of Cancer Research, London, United Kingdom., Rekowski J; The Institute of Cancer Research, London, United Kingdom., Alajati A; Institute of Oncology Research, Università della Svizzera Italiana, Bellinzona, Switzerland., Clarke M; The Institute of Cancer Research, London, United Kingdom., Pereira R; The Institute of Cancer Research, London, United Kingdom., Flohr P; The Institute of Cancer Research, London, United Kingdom., Fowler G; The Institute of Cancer Research, London, United Kingdom., Boysen G; The Institute of Cancer Research, London, United Kingdom., Sumanasuriya S; The Institute of Cancer Research, London, United Kingdom.; The Royal Marsden Hospital, London, United Kingdom., Bianchini D; The Institute of Cancer Research, London, United Kingdom.; The Royal Marsden Hospital, London, United Kingdom., Rescigno P; The Institute of Cancer Research, London, United Kingdom.; The Royal Marsden Hospital, London, United Kingdom., Aversa C; The Institute of Cancer Research, London, United Kingdom.; The Royal Marsden Hospital, London, United Kingdom., Tunariu N; The Institute of Cancer Research, London, United Kingdom.; The Royal Marsden Hospital, London, United Kingdom., Guo C; The Institute of Cancer Research, London, United Kingdom.; The Royal Marsden Hospital, London, United Kingdom., Paschalis A; The Institute of Cancer Research, London, United Kingdom.; The Royal Marsden Hospital, London, United Kingdom., Bertan C; The Institute of Cancer Research, London, United Kingdom., Buroni L; The Institute of Cancer Research, London, United Kingdom., Ning J; The Institute of Cancer Research, London, United Kingdom., Carreira S; The Institute of Cancer Research, London, United Kingdom., Workman P; The Institute of Cancer Research, London, United Kingdom., Swain A; The Institute of Cancer Research, London, United Kingdom., Califano A; Columbia University College of Physicians and Surgeons, New York, New York., Shen MM; Columbia University College of Physicians and Surgeons, New York, New York., Alimonti A; Institute of Oncology Research, Università della Svizzera Italiana, Bellinzona, Switzerland., Neeb A, Welti J; The Institute of Cancer Research, London, United Kingdom., Yuan W; The Institute of Cancer Research, London, United Kingdom., de Bono J; The Institute of Cancer Research, London, United Kingdom. johann.de-bono@icr.ac.uk.; The Royal Marsden Hospital, London, United Kingdom.
Publikováno v:
Cancer research [Cancer Res] 2021 Dec 15; Vol. 81 (24), pp. 6207-6218. Date of Electronic Publication: 2021 Nov 09.
Autor:
Sumanasuriya S; The Institute of Cancer Research, University of London, London, UK; The Royal Marsden Hospital, London, UK., Seed G; The Institute of Cancer Research, University of London, London, UK., Parr H; The Institute of Cancer Research, University of London, London, UK., Christova R; The Institute of Cancer Research, University of London, London, UK., Pope L; The Institute of Cancer Research, University of London, London, UK., Bertan C; The Institute of Cancer Research, University of London, London, UK., Bianchini D; The Institute of Cancer Research, University of London, London, UK; The Royal Marsden Hospital, London, UK., Rescigno P; The Institute of Cancer Research, University of London, London, UK; The Royal Marsden Hospital, London, UK., Figueiredo I; The Institute of Cancer Research, University of London, London, UK., Goodall J; The Institute of Cancer Research, University of London, London, UK., Fowler G; The Institute of Cancer Research, University of London, London, UK., Flohr P; The Institute of Cancer Research, University of London, London, UK., Mehra N; The Institute of Cancer Research, University of London, London, UK; The Royal Marsden Hospital, London, UK., Neeb A; The Institute of Cancer Research, University of London, London, UK., Rekowski J; The Institute of Cancer Research, University of London, London, UK., Eisenberger M; Johns Hopkins University, Baltimore, MD, USA., Sartor O; Tulane Medical School, New Orleans, LA, USA., Oudard S; Hôpital Européen Georges Pompidou and Université de Paris, Paris, France., Geffriaud-Ricouard C; Sanofi-Genzyme, Paris, France., Ozatilgan A; Sanofi-Genzyme, Paris, France., Chadjaa M; Sanofi-Genzyme, Paris, France., Macé S; Sanofi-Genzyme, Paris, France., Lord C; The CRUK Gene Function Laboratory and Breast Cancer Now Research Centre, The Institute of Cancer Research, London, UK., Baxter J; The CRUK Gene Function Laboratory and Breast Cancer Now Research Centre, The Institute of Cancer Research, London, UK., Pettitt S; The CRUK Gene Function Laboratory and Breast Cancer Now Research Centre, The Institute of Cancer Research, London, UK., Lambros M; The Institute of Cancer Research, University of London, London, UK; The Royal Marsden Hospital, London, UK., Sharp A; The Institute of Cancer Research, University of London, London, UK; The Royal Marsden Hospital, London, UK., Mateo J; Vall d'Hebron Institute of Oncology, Barcelona, Spain., Carreira S; The Institute of Cancer Research, University of London, London, UK; The Royal Marsden Hospital, London, UK., Yuan W; The Institute of Cancer Research, University of London, London, UK; The Royal Marsden Hospital, London, UK., de Bono JS; The Institute of Cancer Research, University of London, London, UK; The Royal Marsden Hospital, London, UK. Electronic address: johann.de-bono@icr.ac.uk.
Publikováno v:
European urology [Eur Urol] 2021 Aug; Vol. 80 (2), pp. 243-253. Date of Electronic Publication: 2021 Jun 05.
Autor:
Paschalis A; The Institute of Cancer Research, London, United Kingdom.; The Royal Marsden NHS Foundation Trust, London, United Kingdom., Welti J; The Institute of Cancer Research, London, United Kingdom., Neeb AJ; The Institute of Cancer Research, London, United Kingdom., Yuan W; The Institute of Cancer Research, London, United Kingdom., Figueiredo I; The Institute of Cancer Research, London, United Kingdom., Pereira R; The Institute of Cancer Research, London, United Kingdom., Ferreira A; The Institute of Cancer Research, London, United Kingdom., Riisnaes R; The Institute of Cancer Research, London, United Kingdom., Rodrigues DN; The Institute of Cancer Research, London, United Kingdom., Jiménez-Vacas JM; Maimonides Institute for Biomedical Research of Cordoba (IMIBIC), Cordoba, Spain.; Department of Cell Biology, Physiology, and Immunology, University of Cordoba, Cordoba, Spain.; Hospital Universitario Reina Sofía (HURS), Cordoba, Spain., Kim S; Department of Medicine, University of Washington School of Medicine and VAPSHCS-GRECC, Seattle, Washington., Uo T; Department of Medicine, University of Washington School of Medicine and VAPSHCS-GRECC, Seattle, Washington., Micco PD; The Institute of Cancer Research, London, United Kingdom., Tumber A; Chemistry Research Laboratory, Department of Chemistry, University of Oxford, Oxford, United Kingdom., Islam MS; Chemistry Research Laboratory, Department of Chemistry, University of Oxford, Oxford, United Kingdom., Moesser MA; Chemistry Research Laboratory, Department of Chemistry, University of Oxford, Oxford, United Kingdom., Abboud M; Chemistry Research Laboratory, Department of Chemistry, University of Oxford, Oxford, United Kingdom., Kawamura A; Chemistry Research Laboratory, Department of Chemistry, University of Oxford, Oxford, United Kingdom., Gurel B; The Institute of Cancer Research, London, United Kingdom., Christova R; The Institute of Cancer Research, London, United Kingdom., Gil VS; The Institute of Cancer Research, London, United Kingdom., Buroni L; The Institute of Cancer Research, London, United Kingdom., Crespo M; The Institute of Cancer Research, London, United Kingdom., Miranda S; The Institute of Cancer Research, London, United Kingdom., Lambros MB; The Institute of Cancer Research, London, United Kingdom., Carreira S; The Institute of Cancer Research, London, United Kingdom., Tunariu N; The Institute of Cancer Research, London, United Kingdom.; The Royal Marsden NHS Foundation Trust, London, United Kingdom., Alimonti A, Al-Lazikani B; The Institute of Cancer Research, London, United Kingdom., Schofield CJ; Chemistry Research Laboratory, Department of Chemistry, University of Oxford, Oxford, United Kingdom., Plymate SR; Department of Medicine, University of Washington School of Medicine and VAPSHCS-GRECC, Seattle, Washington., Sharp A; The Institute of Cancer Research, London, United Kingdom.; The Royal Marsden NHS Foundation Trust, London, United Kingdom., de Bono JS; The Institute of Cancer Research, London, United Kingdom. johann.de-bono@icr.ac.uk.; The Royal Marsden NHS Foundation Trust, London, United Kingdom.
Publikováno v:
Cancer research [Cancer Res] 2021 Feb 15; Vol. 81 (4), pp. 1087-1100.
Autor:
Poon E; Division of Clinical Studies and.; Division of Cancer Therapeutics, Institute of Cancer Research (ICR), London and Royal Marsden NHS Trust, Sutton, United Kingdom., Liang T; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, USA., Jamin Y; Division of Radiotherapy and Imaging, ICR, London, United Kingdom., Walz S; Core Unit Bioinformatics, Comprehensive Cancer Center Mainfranken and Theodor Boveri Institute, Biocenter, University of Wurzburg, Wurzburg, Germany., Kwok C; Division of Clinical Studies and.; Division of Cancer Therapeutics, Institute of Cancer Research (ICR), London and Royal Marsden NHS Trust, Sutton, United Kingdom., Hakkert A; Division of Clinical Studies and.; Division of Cancer Therapeutics, Institute of Cancer Research (ICR), London and Royal Marsden NHS Trust, Sutton, United Kingdom., Barker K; Division of Clinical Studies and.; Division of Cancer Therapeutics, Institute of Cancer Research (ICR), London and Royal Marsden NHS Trust, Sutton, United Kingdom., Urban Z; Division of Clinical Studies and.; Division of Cancer Therapeutics, Institute of Cancer Research (ICR), London and Royal Marsden NHS Trust, Sutton, United Kingdom., Thway K; Division of Molecular Pathology, ICR, London, and Royal Marsden NHS Trust, Sutton, United Kingdom., Zeid R; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Hallsworth A; Division of Clinical Studies and.; Division of Cancer Therapeutics, Institute of Cancer Research (ICR), London and Royal Marsden NHS Trust, Sutton, United Kingdom., Box G; Division of Cancer Therapeutics, Institute of Cancer Research (ICR), London and Royal Marsden NHS Trust, Sutton, United Kingdom.; Cancer Research UK, Cancer Therapeutics Unit, ICR, London, United Kingdom., Ebus ME; Prinses Maxima Center for Pediatric Oncology, Utrecht, Netherlands., Licciardello MP; Division of Cancer Therapeutics, Institute of Cancer Research (ICR), London and Royal Marsden NHS Trust, Sutton, United Kingdom.; Cancer Research UK, Cancer Therapeutics Unit, ICR, London, United Kingdom., Sbirkov Y; Division of Clinical Studies and.; Division of Cancer Therapeutics, Institute of Cancer Research (ICR), London and Royal Marsden NHS Trust, Sutton, United Kingdom., Lazaro G; Division of Cancer Therapeutics, Institute of Cancer Research (ICR), London and Royal Marsden NHS Trust, Sutton, United Kingdom., Calton E; Division of Clinical Studies and.; Division of Cancer Therapeutics, Institute of Cancer Research (ICR), London and Royal Marsden NHS Trust, Sutton, United Kingdom., Costa BM; Division of Clinical Studies and.; Division of Cancer Therapeutics, Institute of Cancer Research (ICR), London and Royal Marsden NHS Trust, Sutton, United Kingdom., Valenti M; Division of Cancer Therapeutics, Institute of Cancer Research (ICR), London and Royal Marsden NHS Trust, Sutton, United Kingdom.; Cancer Research UK, Cancer Therapeutics Unit, ICR, London, United Kingdom., De Haven Brandon A; Division of Cancer Therapeutics, Institute of Cancer Research (ICR), London and Royal Marsden NHS Trust, Sutton, United Kingdom.; Cancer Research UK, Cancer Therapeutics Unit, ICR, London, United Kingdom., Webber H; Division of Clinical Studies and.; Division of Cancer Therapeutics, Institute of Cancer Research (ICR), London and Royal Marsden NHS Trust, Sutton, United Kingdom., Tardif N; Division of Clinical Studies and.; Division of Cancer Therapeutics, Institute of Cancer Research (ICR), London and Royal Marsden NHS Trust, Sutton, United Kingdom., Almeida GS; Division of Clinical Studies and.; Division of Cancer Therapeutics, Institute of Cancer Research (ICR), London and Royal Marsden NHS Trust, Sutton, United Kingdom.; Division of Radiotherapy and Imaging, ICR, London, United Kingdom., Christova R; Division of Clinical Studies and., Boysen G; Division of Clinical Studies and., Richards MW; School of Molecular and Cellular Biology, Faculty of Biological Sciences, University of Leeds, Leeds, United Kingdom., Barone G; Division of Clinical Studies and.; Division of Cancer Therapeutics, Institute of Cancer Research (ICR), London and Royal Marsden NHS Trust, Sutton, United Kingdom., Ford A; Division of Molecular Pathology, ICR, London, and Royal Marsden NHS Trust, Sutton, United Kingdom., Bayliss R; School of Molecular and Cellular Biology, Faculty of Biological Sciences, University of Leeds, Leeds, United Kingdom., Clarke PA; Division of Cancer Therapeutics, Institute of Cancer Research (ICR), London and Royal Marsden NHS Trust, Sutton, United Kingdom.; Cancer Research UK, Cancer Therapeutics Unit, ICR, London, United Kingdom., De Bono J; Division of Clinical Studies and., Gray NS; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts, USA., Blagg J; Division of Cancer Therapeutics, Institute of Cancer Research (ICR), London and Royal Marsden NHS Trust, Sutton, United Kingdom.; Cancer Research UK, Cancer Therapeutics Unit, ICR, London, United Kingdom., Robinson SP; Division of Radiotherapy and Imaging, ICR, London, United Kingdom., Eccles SA; Division of Cancer Therapeutics, Institute of Cancer Research (ICR), London and Royal Marsden NHS Trust, Sutton, United Kingdom.; Cancer Research UK, Cancer Therapeutics Unit, ICR, London, United Kingdom., Zheleva D; Cyclacel Ltd., Dundee, United Kingdom., Bradner JE; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts, USA.; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA., Molenaar J; Prinses Maxima Center for Pediatric Oncology, Utrecht, Netherlands., Vivanco I; Division of Cancer Therapeutics, Institute of Cancer Research (ICR), London and Royal Marsden NHS Trust, Sutton, United Kingdom., Eilers M; Comprehensive Cancer Center Mainfranken and Theodor Boveri Institute, Biocenter, University of Wurzburg, Wurzburg, Germany., Workman P; Division of Cancer Therapeutics, Institute of Cancer Research (ICR), London and Royal Marsden NHS Trust, Sutton, United Kingdom.; Cancer Research UK, Cancer Therapeutics Unit, ICR, London, United Kingdom., Lin CY; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, USA., Chesler L; Division of Clinical Studies and.; Division of Cancer Therapeutics, Institute of Cancer Research (ICR), London and Royal Marsden NHS Trust, Sutton, United Kingdom.
Publikováno v:
The Journal of clinical investigation [J Clin Invest] 2020 Nov 02; Vol. 130 (11), pp. 5875-5892.
Autor:
Tavares, Valéria1,2,3 (AUTHOR) jpimenta@chtmad.min-saude.pt, Savva-Bordalo, Joana4 (AUTHOR) joana.sa@ipoporto.min-saude.pt, Rei, Mariana5 (AUTHOR) marianacruzrei@gmail.com, Liz-Pimenta, Joana3,6 (AUTHOR), Assis, Joana7 (AUTHOR) joana.assis@ipoporto.min-saude.pt, Pereira, Deolinda4 (AUTHOR) dpereira@ipoporto.min-saude.pt, Medeiros, Rui1,2,3,8,9 (AUTHOR) ruimedei@ipoporto.min-saude.pt
Publikováno v:
Biomolecules (2218-273X). Aug2024, Vol. 14 Issue 8, p928. 23p.
Autor:
Kluge K; Department of Biomedical Imaging and Image-Guided Therapy, Division of Nuclear Medicine, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria.; Christian Doppler Laboratory for Applied Metabolomics (CDL AM), Medical University of Vienna, Vienna, Austria., Einspieler H; Department of Biomedical Imaging and Image-Guided Therapy, Division of Nuclear Medicine, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria., Haberl D; Department of Biomedical Imaging and Image-Guided Therapy, Division of Nuclear Medicine, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria.; Christian Doppler Laboratory for Applied Metabolomics (CDL AM), Medical University of Vienna, Vienna, Austria., Spielvogel C; Department of Biomedical Imaging and Image-Guided Therapy, Division of Nuclear Medicine, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria.; Christian Doppler Laboratory for Applied Metabolomics (CDL AM), Medical University of Vienna, Vienna, Austria., Amereller D; Department of Biomedical Imaging and Image-Guided Therapy, Division of Nuclear Medicine, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria., Egger G; Department of Pathology, Medical University of Vienna, Vienna, Austria., Kramer G; Department of Urology, Medical University of Vienna, Vienna, Austria., Grubmüller B; Department of Urology and Andrology, University Hospital Krems, Krems, Austria.; Karl Landsteiner University of Health Sciences, Krems, Austria., Shariat S; Department of Urology, Medical University of Vienna, Vienna, Austria.; Karl Landsteiner Institute of Urology and Andrology, Vienna, Austria.; Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX, USA.; Department of Special Surgery, Division of Urology, The University of Jordan, Amman, Jordan.; Department of Urology, Second Faculty of Medicine, Charles University, Prague, Czech Republic.; Department of Urology, Weill Cornell Medical College, New York, NY, USA., Hacker M; Department of Biomedical Imaging and Image-Guided Therapy, Division of Nuclear Medicine, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria., Kenner L; Christian Doppler Laboratory for Applied Metabolomics (CDL AM), Medical University of Vienna, Vienna, Austria.; Department of Pathology, Medical University of Vienna, Vienna, Austria., Haug A; Department of Biomedical Imaging and Image-Guided Therapy, Division of Nuclear Medicine, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria. alexander.haug@meduniwien.ac.at.; Christian Doppler Laboratory for Applied Metabolomics (CDL AM), Medical University of Vienna, Vienna, Austria. alexander.haug@meduniwien.ac.at.
Publikováno v:
European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2024 Jul; Vol. 51 (9), pp. 2833-2842. Date of Electronic Publication: 2024 May 02.